GT
NTR icon

Glenmede Trust’s Nutrien NTR Stock Holding History

Glenmede Trust’s Portfolio NTR Stock Details NTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$547K Buy
8,683
+2,042
+31% +$143K ﹤0.01% 958
2026
Q1 		$501K Buy
6,641
+112
+2% +$7.99K ﹤0.01% 960
2025
Q4 		$403K Buy
+6,529
New +$384K ﹤0.01% 1018
2025
Q1 		$249K Buy
+5,009
New +$256K ﹤0.01% 1146
2024
Q4 		– Sell
-6,634
Closed -$319K – 1440
2024
Q3 		$319K Sell
6,634
-144
-2% -$6.94K ﹤0.01% 1077
2024
Q2 		$345K Sell
6,778
-221
-3% -$12.1K ﹤0.01% 1010
2024
Q1 		$380K Sell
6,999
-94
-1% -$4.9K ﹤0.01% 998
2023
Q4 		$400K Sell
7,093
-4,521
-39% -$255K ﹤0.01% 963
2023
Q3 		$717K Buy
11,614
+2,923
+34% +$185K ﹤0.01% 728
2023
Q2 		$642K Hold
8,691
– – ﹤0.01% 767
2023
Q1 		$642K Sell
8,691
-916
-10% -$70.7K ﹤0.01% 769
2022
Q4 		$702K Sell
9,607
-766
-7% -$60.5K ﹤0.01% 744
2022
Q3 		$863K Buy
10,373
+1,306
+14% +$112K 0.01% 683
2022
Q2 		$721K Sell
9,067
-132
-1% -$12.8K ﹤0.01% 757
2022
Q1 		$956K Sell
9,199
-2,119
-19% -$176K ﹤0.01% 734
2021
Q4 		$850K Buy
11,318
+1,262
+13% +$88.3K ﹤0.01% 787
2021
Q3 		$651K Hold
10,056
– – ﹤0.01% 825
2021
Q2 		$608K Sell
10,056
-480
-5% -$28.4K ﹤0.01% 828
2021
Q1 		$566K Buy
10,536
+1,492
+16% +$81.1K ﹤0.01% 812
2020
Q4 		$434K Sell
9,044
-574
-6% -$25.4K ﹤0.01% 872
2020
Q3 		$376K Sell
9,618
-505
-5% -$18.4K ﹤0.01% 867
2020
Q2 		$324K Sell
10,123
-6,479
-39% -$225K ﹤0.01% 883
2020
Q1 		$794K Hold
16,602
– – ﹤0.01% 787
2019
Q4 		$794K Sell
16,602
-132
-0.8% -$6.38K ﹤0.01% 787
2019
Q3 		$834K Buy
16,734
+726
+5% +$37K ﹤0.01% 772
2019
Q2 		$855K Sell
16,008
-384
-2% -$20K ﹤0.01% 777
2019
Q1 		$864K Buy
16,392
+3,850
+31% +$201K ﹤0.01% 767
2018
Q4 		$589K Buy
12,542
+1,103
+10% +$57.5K ﹤0.01% 828
2018
Q3 		$659K Buy
11,439
+150
+1% +$8.3K ﹤0.01% 834
2018
Q2 		$614K Buy
+11,289
New +$560K ﹤0.01% 796

Other funds holding NTR

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Glenmede Trust's NTR Position: Q2 2026 in Review

Glenmede Trust increased its Nutrien (NTR) stake by 31% in Q2 2026, buying an estimated $143K and bringing the position to 8,683 shares worth $547K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Glenmede Trust first reported a position in NTR in Q2 2018 and has held it in 30 quarters since. The position peaked at $956K in Q1 2022. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Glenmede Trust held 8,683 shares of Nutrien worth $547K as of Q2 2026.
  • Glenmede Trust bought 2,042 Nutrien shares in Q2 2026, an estimated $143K.
  • Nutrien made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #958 holding.
  • Glenmede Trust first reported a position in Nutrien in Q2 2018 and has held it in 30 quarters since.
  • Glenmede Trust's Nutrien position peaked at $956K in Q1 2022.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.